BCL2 gene break apart rearrangement probe, BCL2 (CE-IVD)
Catalog No : FP-037
513.00€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | BCL2 gene break apart rearrangement probe, BCL2 (CE-IVD) | ||
|---|---|---|---|
| Catalog No | FP-037 | ||
| Supplier’s Catalog No | FP-037 | ||
| Supplier | Wuhan Healthcare Biotech | ||
| Source antigen | BCL2 | ||
| Reactivity | BCL2 | ||
| Cross reactivity | None | ||
| Applications | Fluorescence In Situ Hybridization (FISH) | ||
| Molecular weight | N/A | ||
| Storage | -20°C | ||
|---|---|---|---|
| Other names | |||
| Grade | Molecular diagnostic grade | ||
| Purity | N/A | ||
| Form | Liquid | ||
| Reactivity life | 12 months when stored properly according to instructions | ||
| Note | For Professional In Vitro diagnostics | ||
| Description | Follicular lymphoma (FL) is a less malignant B cell tumor derived from the center of follicle development. FL is a common type of non-Hodgkin's lymphoma (NHL), accounting for about 10% of NHL in China and 25%-45% of NHL in Europe and America. BCL2/IGH rearrangement occurs in approximately 80%-85% of FL, t(14;18) (q32;q21) reciprocal translocation of BCL2 proto-oncogene with ICH gene; BCL2/IGH rearrangement survival rate is shortened, prognosis difference. In addition to its primary fusion with the IGH gene, it has also been found that BCL2 can be fused to other genes (eg AFF3, IGHL, etc.). | ||
Product Details
© 2020 Imugex All Rights Reserved